Galmed Pharmaceuticals

EOCNNasdaq Israel Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$3.625 M

$3.48 +2.05%

Close of 17 Sept 2026

Revenue

—

Not reported

Earnings

-$10.3M

Loss-making

Shares outstanding

6,581,390

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Other share classes

Galmed Pharmaceuticals lists more than one class of stock. Company figures above cover all classes combined.

GLMD

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →

#472Revelation BiosciencesREVB$3.78M
#473Mustang BioMBIO$3.71M
#474Galmed PharmaceuticalsEOCN$3.62M
#475RedHill BiopharmaRDHL$3.60M
#476HCW BiologicsHCWB$3.58M

What if Galmed Pharmaceuticals were worth as much as…

Open the what-if tool →

Gold $30.3T

$29,085,490

Per share 8,357,899× higher

Bitcoin $1.54T

$1,476,539

Per share 424,293× higher

Nvidia $5.29T

$5,075,146

Per share 1,458,375× higher

Or at a round number

$5.00M $10.0M $20.0M $50.0M

Where these numbers come from

Share counts and financials for Galmed Pharmaceuticals are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 18 Sept 2026. Read the methodology.